Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice:

NCT06322238 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Pharmacogenomic Drug Interaction
Side Effect of Drug
Ineffective Drug Action
Drug Metabolism, Poor, CYP2D6-Related
Drug Metabolism, Poor, CYP2C19-Related

Interventions

DIAGNOSTIC_TEST: PGx panel test

Sponsor

Mayo Clinic